CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 53 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,019,831 | -21.5% | 258,326 | -9.8% | 0.00% | -33.3% |
| Q2 2023 | $3,849,310 | -46.3% | 286,407 | -33.7% | 0.00% | -40.0% |
| Q1 2023 | $7,167,600 | +33.3% | 432,304 | +49.5% | 0.01% | +25.0% |
| Q4 2022 | $5,378,506 | -1.3% | 289,167 | -31.9% | 0.00% | 0.0% |
| Q3 2022 | $5,448,000 | +273.2% | 424,637 | +103.9% | 0.00% | +300.0% |
| Q2 2022 | $1,460,000 | +198.6% | 208,229 | +253.4% | 0.00% | – |
| Q1 2022 | $489,000 | -65.9% | 58,927 | -72.2% | 0.00% | -100.0% |
| Q4 2021 | $1,434,000 | +104.6% | 211,835 | +60.1% | 0.00% | – |
| Q3 2021 | $701,000 | -58.6% | 132,296 | -55.1% | 0.00% | -100.0% |
| Q2 2021 | $1,693,000 | -45.4% | 294,504 | -56.3% | 0.00% | -50.0% |
| Q1 2021 | $3,103,000 | +4463.2% | 673,233 | +3183.1% | 0.00% | – |
| Q4 2020 | $68,000 | +195.7% | 20,506 | +166.0% | 0.00% | – |
| Q3 2020 | $23,000 | -95.8% | 7,710 | -93.5% | 0.00% | – |
| Q2 2020 | $549,000 | -6.2% | 118,878 | -21.7% | 0.00% | -100.0% |
| Q1 2020 | $585,000 | -22.4% | 151,829 | -24.5% | 0.00% | 0.0% |
| Q4 2019 | $754,000 | +58.7% | 201,130 | +124.8% | 0.00% | – |
| Q3 2019 | $475,000 | +361.2% | 89,474 | +232.2% | 0.00% | – |
| Q2 2019 | $103,000 | -23.1% | 26,932 | +3.0% | 0.00% | – |
| Q1 2019 | $134,000 | +173.5% | 26,145 | +3.3% | 0.00% | – |
| Q4 2018 | $49,000 | -51.0% | 25,312 | -4.4% | 0.00% | – |
| Q3 2018 | $100,000 | +44.9% | 26,477 | +19.3% | 0.00% | – |
| Q2 2018 | $69,000 | -26.6% | 22,190 | -43.3% | 0.00% | – |
| Q1 2018 | $94,000 | +235.7% | 39,130 | +443.3% | 0.00% | – |
| Q4 2017 | $28,000 | – | 7,202 | +5234.8% | 0.00% | – |
| Q3 2017 | $0 | – | 135 | -25.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 180 | -95.6% | 0.00% | – |
| Q1 2017 | $8,000 | +100.0% | 4,088 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | 0.0% | 4,088 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | -50.0% | 4,088 | -64.3% | 0.00% | – |
| Q2 2016 | $8,000 | -90.7% | 11,438 | -84.5% | 0.00% | – |
| Q1 2016 | $86,000 | +53.6% | 73,612 | +224.1% | 0.00% | – |
| Q4 2015 | $56,000 | – | 22,716 | +189200.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 12 | -98.8% | 0.00% | – |
| Q2 2015 | $4,000 | – | 979 | +3396.4% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 28 | -99.7% | 0.00% | – |
| Q3 2014 | $34,000 | +277.8% | 10,096 | +185.4% | 0.00% | – |
| Q2 2014 | $9,000 | +800.0% | 3,538 | +607.6% | 0.00% | – |
| Q4 2013 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |